8-KOther EventsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Corporate Update (May 29, 2013)

Filed May 29, 2013For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed this Current Report on Form 8-K to retroactively update its previously filed 2012 Annual Report (10-K) and its Q1 2013 Quarterly Report (10-Q) to reflect a significant change in its business structure. Effective January 1, 2013, the company reorganized its operations from a geographic region-based structure to a global business unit (GBU) structure. This change impacts how the company manages and reports its business segments. The primary purpose of this filing is to provide updated disclosures within the 2012 Form 10-K to align with this new GBU reporting structure. This includes revisions to discussions regarding international operations, net sales by segment, goodwill impairment charges, goodwill valuation, and the use of non-GAAP financial measures. Investors should note that this 8-K does not introduce new events or developments after February 22, 2013, and should be read in conjunction with the company's more recent filings, particularly the Q1 2013 Form 10-Q, for the most current information.

Key Highlights

  • 1Boston Scientific has reorganized its business segments from geographic regions to Global Business Units (GBUs) effective January 1, 2013.
  • 2This 8-K filing retroactively updates the 2012 Form 10-K to reflect the new GBU segment structure.
  • 3Revisions impact multiple sections of the 2012 10-K, including revenue reporting, goodwill impairment, and segment disclosures.
  • 4The company is providing updated disclosures on international operations, net sales by reportable segment, and goodwill valuation.
  • 5Discussions on the use of non-GAAP financial measures have also been revised to align with the new segment reporting.
  • 6This filing serves to provide consistency in financial reporting following the internal restructuring.
  • 7Investors are advised to consult more recent filings, such as the Q1 2013 10-Q, for information subsequent to February 22, 2013.

Frequently Asked Questions

Boston Scientific is filing this 8-K to retroactively update its previously filed 2012 Annual Report (10-K) and Q1 2013 Quarterly Report (10-Q). The company reorganized its business from geographic regions into global business units (GBUs) effective January 1, 2013, and this filing ensures the 2012 financial disclosures reflect this new operational and reporting structure.

Several sections of the 2012 10-K are revised, including discussions on international operations, net sales by reportable segment, goodwill impairment charges, goodwill valuation (reporting units), the use of non-GAAP financial measures, and segment reporting notes. The table allocating goodwill acquired in 2012 by reportable segment has also been removed.

No, this Current Report on Form 8-K does not reflect events or developments that occurred after February 22, 2013. It solely serves to update previously filed information to reflect the change in the company's reportable segments. For more current information, investors should refer to Boston Scientific's Q1 2013 Form 10-Q and other subsequent SEC filings.

The change allows for a more granular view of performance by product-focused global business units rather than broad geographic areas. This could provide better insights into the operational effectiveness and growth drivers of specific product lines. Investors should analyze the revised segment data to understand the performance and strategic focus of each GBU.